The role of sarcopenia questionnaires in hospitalized patients with chronic heart failure

[11] Morley JE(2014)Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 15 630-634

[12] Rossi AP(2017)Development of a Japanese version of the SARC-F for diabetic patients: an examination of reliability and validity Aging Clin Exp Res 29 935-942

[13] Micciolo R(2017)Association between sarcopenia and mild cognitive impairment using the Japanese version of the SARC-F in elderly patients with diabetes J Am Med Dir Assoc 18 809.e9-809.e13

[14] Rule S(2016)Cross-cultural adaptation and validation of the Spanish-language version of the SARC-F to assess sarcopenia in Mexican community-dwelling older adults J Am Med Dir Assoc 17 1142-1146

[15] Testa G(2016)Sarcopenia screened with SARC-F questionnaire is associated with quality of life and 4-year mortality J Am Med Dir Assoc 17 1129-1135

[16] Liguori I(2016)SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes J Cachexia Sarcopenia Muscle 7 28-36

[17] Curcio F(2019)Comparing mini sarcopenia risk assessment with SARC-F for Screening sarcopenia in community-dwelling older adults J Am Med Dir Assoc 20 1-5

[18] Liguori I(2010)Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People Age Ageing 39 412-423

[19] Russo G(2014)Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia J Am Med Dir Assoc 15 95-101

[20] Ara L(2011)Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. international working group on sarcopenia J Am Med Dir Assoc 12 249-256

[11] Morley JE(2014)Validating the SARC-F: a suitable community screening tool for sarcopenia? J Am Med Dir Assoc 15 630-634

[12] Rossi AP(2017)Development of a Japanese version of the SARC-F for diabetic patients: an examination of reliability and validity Aging Clin Exp Res 29 935-942

[13] Micciolo R(2017)Association between sarcopenia and mild cognitive impairment using the Japanese version of the SARC-F in elderly patients with diabetes J Am Med Dir Assoc 18 809.e9-809.e13

[14] Rule S(2016)Cross-cultural adaptation and validation of the Spanish-language version of the SARC-F to assess sarcopenia in Mexican community-dwelling older adults J Am Med Dir Assoc 17 1142-1146

[15] Testa G(2016)Sarcopenia screened with SARC-F questionnaire is associated with quality of life and 4-year mortality J Am Med Dir Assoc 17 1129-1135

[16] Liguori I(2016)SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes J Cachexia Sarcopenia Muscle 7 28-36

[17] Curcio F(2019)Comparing mini sarcopenia risk assessment with SARC-F for Screening sarcopenia in community-dwelling older adults J Am Med Dir Assoc 20 1-5

[18] Liguori I(2010)Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People Age Ageing 39 412-423

[19] Russo G(2014)Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia J Am Med Dir Assoc 15 95-101

[20] Ara L(2011)Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. international working group on sarcopenia J Am Med Dir Assoc 12 249-256